About StoneWise
StoneWise is a company based in Haidian (China) founded in 2018 by Zhou Jielong. StoneWise has raised $100 million across 4 funding rounds from investors including Hillhouse, Linear Capital and Long Hill Capital. StoneWise operates in a competitive market with competitors including Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
- Headquarter Haidian, China
- Founders Zhou Jielong
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$100 M (USD)
in 4 rounds
-
Latest Funding Round
$100 M (USD), Series B
Apr 12, 2021
-
Investors
Hillhouse
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of StoneWise
StoneWise has successfully raised a total of $100M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $100 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in StoneWise
StoneWise has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Hillhouse, Linear Capital and Long Hill Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed with long-term focus.
|
Locked | Locked | Locked | |
|
Linear Capital is recognized as a frontier tech investment fund.
|
Locked | Locked | Locked | |
|
Tech and offline sectors in China are targeted for investments.
|
Locked | Locked | Locked |
Investor details for StoneWise
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by StoneWise
Investment portfolio details for StoneWise
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - StoneWise
Detailed financials for StoneWise
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stonewise Comparisons
Peer comparison for StoneWise
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of StoneWise
StoneWise operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| Locked | Locked | Locked |
Developer of drugs to treat various diseases
|
|
| Locked | Locked | Locked |
Provider of machine language and computational platform for drug discovery
|
|
| Locked | Locked | Locked |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| Locked | Locked | Locked |
Digital technology for biomedicinal molecule development in research is utilized.
|
|
| Locked | Locked | Locked |
Provider of software solutions for molecular diagnostics and discovery
|
Detailed competitors of StoneWise
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stonewise
Complete news archive for StoneWise
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about StoneWise
StoneWise was founded in 2018.
StoneWise is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.
Zhou Jielong is the current CEO of StoneWise. They have also founded this company.
StoneWise is a funded company, having raised a total of $100M across 4 funding rounds to date.
StoneWise was founded in 2018 and is based in Haidian, China. Software solutions for molecular modeling in the biotechnology sector are developed and offered. Artificial intelligence is employed for molecule design, synthetic product prediction, and drug knowledge mining. Operations focus on tools that support research in pharmaceuticals and chemical synthesis.
StoneWise has 8 investors. Key investors include Hillhouse, Linear Capital, Long Hill Capital, Legend Capital, and Lightspeed China Partners.